110 related articles for article (PubMed ID: 8683891)
21. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
22. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
23. Failure of adjuvant chemotherapy in testicular cancer.
Bernstein JI; Freiha F; Breeden J; Torti FM
Cancer; 1987 Oct; 60(8):1729-30. PubMed ID: 2443231
[TBL] [Abstract][Full Text] [Related]
24. [High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) For advanced testicular cancer].
Fujii Y; Kihara K; Kamata S; Tsujii T; Ishizaka K; Kageyama Y; Masuda H; Arisawa C; Oshima H; Komatsu F
Hinyokika Kiyo; 1998 May; 44(5):313-8. PubMed ID: 9656101
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
Pizzocaro G; Piva L; Salvioni R; Zanoni F; Milani A
Cancer; 1985 Nov; 56(10):2411-5. PubMed ID: 2412683
[TBL] [Abstract][Full Text] [Related]
26. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
[TBL] [Abstract][Full Text] [Related]
27. Drug dose delivery and treatment outcome relationship in standard bleomycin, etoposide and cisplatin combination chemotherapy in nonseminomatous germ cell tumor patients.
Gutierrez-Delgado F; Titov DA; Tjulandin SA; Garin AM
Neoplasma; 1999; 46(3):190-5. PubMed ID: 10613596
[TBL] [Abstract][Full Text] [Related]
28. Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
Broun ER; Nichols CR; Gize G; Cornetta K; Hromas RA; Schacht B; Einhorn LH
Cancer; 1997 Apr; 79(8):1605-10. PubMed ID: 9118046
[TBL] [Abstract][Full Text] [Related]
29. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
30. Salvage therapy in recurrent testicular cancer.
Saxman S
Semin Oncol; 1992 Apr; 19(2):143-7. PubMed ID: 1372756
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy of disseminated germ cell tumors.
Einhorn LH
Cancer; 1987 Aug; 60(3 Suppl):570-3. PubMed ID: 2439185
[TBL] [Abstract][Full Text] [Related]
32. [Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria].
Mikami K; Nakagawa S; Sugimoto K; Nomoto T; Urano S; Watanabe H; Iwamoto N; Yamazaki S; Hiratake Y; Maegawa M
Hinyokika Kiyo; 1997 Aug; 43(8):561-6. PubMed ID: 9310778
[TBL] [Abstract][Full Text] [Related]
33. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
34. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
[TBL] [Abstract][Full Text] [Related]
35. [VAB-6 combination chemotherapy in patients with stage II, III testicular tumor].
Hida S; Kawakita M; Takenawa J; Fukuzawa S; Okuno H; Yamauchi T; Oishi K; Nishio Y; Takeuchi H; Okada K
Hinyokika Kiyo; 1986 Dec; 32(12):1849-58. PubMed ID: 2435134
[TBL] [Abstract][Full Text] [Related]
36. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients.
Mencel PJ; Motzer RJ; Mazumdar M; Vlamis V; Bajorin DF; Bosl GJ
J Clin Oncol; 1994 Jan; 12(1):120-6. PubMed ID: 7505805
[TBL] [Abstract][Full Text] [Related]
37. [A randomized trial of PVB, VAB-6, BVP regimen versus PEB chemotherapy in patients with disseminated testicular tumors].
Fukui I; Komatsubara S; Akaza H; Sakashita S; Akasaka Y; Tobisu K; Yamauchi T; Deguchi N; Furuhata A; Kawai T
Nihon Hinyokika Gakkai Zasshi; 1991 Jun; 82(6):976-83. PubMed ID: 1715416
[TBL] [Abstract][Full Text] [Related]
38. [Results of chemotherapy and salvage surgery for advanced testicular cancer].
Saiki S; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T; Miki T
Hinyokika Kiyo; 1999 Nov; 45(11):777-81. PubMed ID: 10637743
[TBL] [Abstract][Full Text] [Related]
39. [Results of treatment for germ cell tumor--dose intensity of chemotherapy and residual masses after chemotherapy].
Matsuzaki J; Miyoshi Y; Miura T
Hinyokika Kiyo; 2000 Dec; 46(12):879-86. PubMed ID: 11211804
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of metastatic seminoma by chemotherapy.: an experience].
Komatsubara S; Itoi T; Watanabe M; Kitamura Y; Koike T
Nihon Hinyokika Gakkai Zasshi; 2000; 91(10-11):666-72. PubMed ID: 11109817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
